Fig. 5

Dash et al., 2022 - Nucleolin loss of function leads to aberrant Fibroblast Growth Factor signaling and craniofacial anomalies
Other Figures
All Figure Page
Back to All Figure Page
Fig. 5

Nucleolin regulates Fgf8a expression. (A) Immunostaining of 36 hpf ncl+/+ and ncl−/− embryos with an Fgf8a-specific antibody reveals reduced expression of Fgf8a in ncl−/− embryos (n=15). (B) qPCR using craniofacial tissues from ncl+/+ and ncl−/− embryos at 18, 24, 30 and 36 hpf indicates that ncl and fgf8a expression gradually reduce over time (n=10 per replicate). (C) RNA immunoprecipitation followed by qPCR indicates higher binding of fgf8a mRNA to Nucleolin compared with the IgG control. actb was used as a negative control (n=100 per replicate per condition). The y-axis indicates fold change of RNA pulldown compared with its absolute expression in the embryos. (D-F) Skeletal preparations of 5 dpf ncl+/+ and ncl−/− larvae as controls (D) for 0.25 µg/µl (E) and 1 µg/µl (F) FGF8 exogenous treatment. Exogenous FGF8 rescued the cranioskeletal phenotype of ncl−/− larvae (n=45). Black arrows indicate the improvement of the basihyal phenotype in FGF8-treated larvae. All experiments were performed three times. Scale bars: 100 µm (A); 70 µm (D-F). Data are represented as mean±s.d. ns, not significant; *P<0.05 (two-tailed, paired Student's t-test).

Expression Data
Anatomical Terms:
Stage Range: 14-19 somites to Prim-25

Expression Detail
Antibody Labeling
Phenotype Data
Observed In:
Stage Range: Prim-5 to Day 5

Phenotype Detail
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Development